Is Medpace Holdings Inc (MEDP) overvalued? · P/E 25, rev $2.53B
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
This page asks whether Medpace Holdings Inc (MEDP) looks expensive on cached numbers — not a short thesis.
Latest reported MEDP revenue for 2025-12-31 was $2.53B. Net income was $451.1M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
MEDP currently screens at market cap $9.30B and trailing P/E 24.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MEDP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MEDP stock page for the full model, not this heading.
Not investment advice.